Status:
ACTIVE_NOT_RECRUITING
Preclinical Study Towards an Immunotherapy in Adrenocortical Carcinoma
Lead Sponsor:
University of Wuerzburg
Collaborating Sponsors:
Deutsche Krebshilfe e.V., Bonn (Germany)
Conditions:
Adrenocortical Carcinoma
Cushing's Syndrome
Eligibility:
All Genders
18+ years
Brief Summary
Adrenocortical carcinoma (ACC) is a rare and heterogeneous malignancy with poor prognosis. Surgical resection of the tumor is the treatment of choice. However, even after complete resection more than ...
Eligibility Criteria
Inclusion
- patients with histological proven adrenocortical carcinoma
- healthy persons as control group
- Life expectancy \> 6 months
Exclusion
- autoimmune diseases
- severe clinical condition
Key Trial Info
Start Date :
September 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2028
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT00457587
Start Date
September 1 2005
End Date
December 1 2028
Last Update
August 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dept. of Medicine I, University of Wuerzburg
Würzburg, Germany, 97080